Thorne HealthTech Financials

THRNDelisted Stock  USD 6.40  0.48  8.11%   
Based on the key indicators obtained from Thorne HealthTech's historical financial statements, Thorne HealthTech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past Thorne HealthTech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Thorne HealthTech's financial statements are interrelated, with each one affecting the others. For example, an increase in Thorne HealthTech's assets may result in an increase in income on the income statement.

Thorne HealthTech Stock Summary

Thorne HealthTech competes with Seneca Foods, Central Garden, Central Garden, Natures Sunshine, and Associated British. Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS8852601090
Business Address152 West 57th
SectorFood Products
IndustryConsumer Staples
BenchmarkDow Jones Industrial
Websitewww.thorne.com
Phone929 251 6321
CurrencyUSD - US Dollar

Thorne HealthTech Key Financial Ratios

Thorne Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Thorne HealthTech's current stock value. Our valuation model uses many indicators to compare Thorne HealthTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Thorne HealthTech competition to find correlations between indicators driving Thorne HealthTech's intrinsic value. More Info.
Thorne HealthTech is currently regarded as top stock in price to earning category among its peers. It is rated below average in revenue category among its peers totaling about  2,282,748  of Revenue per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Thorne HealthTech's earnings, one of the primary drivers of an investment's value.

Thorne HealthTech Market Pulse

 Quote6.40
 Change(%)  8.11 
 Change0.48 
 Open5.92
 Low5.8
 High6.4
 Volume0
 ExchangeNASDAQ

Thorne HealthTech November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Thorne HealthTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Thorne HealthTech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Thorne HealthTech based on widely used predictive technical indicators. In general, we focus on analyzing Thorne Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Thorne HealthTech's daily price indicators and compare them against related drivers.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes